Effects of SCH 42495, a neutral endopeptidase inhibitor, on cardiac function and mass in rats after repeated hyperbaric exposures

REFERENCES

• Carabello BA, Nakano K, Corin W, Biederman R, Spann JF Jr. Left ventricular function in experi-mental volume overload hypertrophy. Am J Physiol 1989; 256 (Heart Circ Physiol 25): H974—H81.
   Google Scholar
• Mxhle BO, Giertsen JC, Tyssebotn I. Hypertro-phy of the left cardiac ventricle in professional divers. J Hyperbaric Med 1989; 89: 189–95.
   Google Scholar
• Stuhr LEB, Bergo GW, Skei S, Mxhle BO, Tyssebotn I. Repeated normoxic hyperbaric expo-sures induce haemodynamic and myocardial changes in rats. Eur J Appl Physiol 1993; 66: 226— 34.
   Google Scholar
• Waldenström A. The renin-angiotensin-aldoster-one system, and its inhibition in cardiac hyper- trophy and insufficiency. In: Schynghedauw B, Research in cardiac hypertrophy and failure. INSERM: John Libbey Eurotext, 1990: 605–17
   Google Scholar
• Raya TE, Fonken SJ, Lee RW, Dauherty S, Goldman S. Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure. Am J Hypertens 1991; 4 Suppl: 334S —49S.
   Google Scholar
• Dahlifif B. The importance of the renin-angiotensin system in reversal of left ventricular hypertrophy. J Hypertens 1993; 11: 29S — 35S.
   Google Scholar
• Scoemaker RG, Debets JJM, Smits JFM. Effects of captopril on cardiac function in heart failure cannot be explained by angiotensin II-1 receptor mediated mechanisms. FASEB J 1991; 5: 841.
   Google Scholar
• Stuhr LEB, Maehle BO. The effect of Losartan, an angiotensin II antagonist, on cardiac function, mass and morphology in rats after repeated hyperbaric exposures. J Scand Clin Lab Invest 1997; 57: 253–62.
   PubMed Web of Science ®Google Scholar
• Ruskoaho H, Leppaluoto J. Immunoreactive atrial natriuretic peptide in ventricles, atria, hypothala-mus, and plasma of genetically hypertensive rats. Circ Res 1988; 62: 384–94.
   PubMed Web of Science ®Google Scholar
• Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte hemostasis. N Engl J Med 1985; 313: 1330–40.
   PubMed Web of Science ®Google Scholar
• Chabrier PE, Roubert P, Lonchampt MO, Plas P, Braquet P. Receptor regulation of atrial natri-uretic factor. Blood Vessel 1990; 27: 153–61.
   Google Scholar
• Sybertz EJ, Chiu JS, Vemulapalli S, Pitts B, Foster CJ, Watkins W, Barnett A, Haslanger MF. Sch 39370, a neutral metallic endopeptidase inhibitor, potentiates biological responses to atrial natriure-tic factor and lowers blood pressure in deoxycor-ticosterone acetate-sodium hypertensive rats. J Pharmacol Exp Ther 1989; 250: 624–31.
   PubMed Web of Science ®Google Scholar
• Watkins RW, Vemulapalli S, Chiu PSJ, Foster C, Smith EM, Neustadt B, Haslanger MF, Sybertz EJ. Atrial natriuretic factor potentiating and hemodynamic effects of 42495, a new, neutral metalloendopeptidase inhibitor. Am J Hypertens 1993; 6: 357–68.
   PubMed Web of Science ®Google Scholar
• Hordnes C, Tyssebotn I. Effect of high ambient pressure and oxygen tension on organ blood flow in conscious trained rats. Undersea Biomed Res 1985; 12: 115–28.
   PubMedGoogle Scholar
• Risberg J, Bergo GW, Hordnes C, Tyssebotn I. Distribution of cardiac output in awake rats during exposure to 5 bar. Undersea Biomed Res 1990; 17: 503–14.
   PubMedGoogle Scholar
• Aanderud L, Onarheim J, Tyssebotn I. Effect of 71 ATA He-02 on organ blood flow in the rat. J Appl Physiol 1985; 2259: 69–1375.
   Google Scholar
• Thomphson JS, Sheedy W, Morice AH. Effects of the neutral endopeptidase inhibitor, SCH 42495, on the cardiovascular remodelling secondary to chronic hypoxia in rats. Clin Sci 1994; 87: 109–14.
   Google Scholar
• Dunn BR, Ichikawa I, Pfeffer JM. Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ Res 1989; 59: 237–46.
   Google Scholar
• Chipkin RE, Berger JG, Billard W, Iorio LC, Chapman R, Barnett A. Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic. J Pharmacol Exp Ther 1989; 245: 829–38.
   Google Scholar
• Sybertz EJ, Chiu PJS, Watkins RW, Vemulapalli S. Natural endopeptidase inhibition: a novel means of circulatory modulation. J Hypertens 1990; 8: 161–7.
   Google Scholar
• Kokkonen JO, Kuoppala A, Saarinen J, Lindtstedt KA, Kounen PT. Kallidin- and bradi-kinin-degrading pathway in human heart: degra-dation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase. Circulation 1999; 99: 1984–90.
   Google Scholar
• Campbell DJ, Anastasopoulos D, Duncan AM, Kladis A, Briscoe TA. Effects of neutral endo-peptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats. J Pharmacol Exp Ther 1998; 287: 567–77.
   Google Scholar
• Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myo-cardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. J Pharmacol Exp Ther 1999; 289: 295–303.
   Google Scholar
• Mercadier JJ, Michel JB. Neurohormonal axis in cardiac hypertension and failure. Research. In: Swynghedauw B, Cardiac hypertrophy and failure. INSERM: John Libby Eurotext 1990; 485–520
   Google Scholar
• Re RN. The myocardial intracellular renin-angio-tensin system. Am J Cardiol 1987; 59: 54–8.
   Google Scholar
• Appel RG. Growth inhibitory activity of atrial natriuretic factor in rat glomerular mesangial cells. FEBS Lett 1988; 238: 135–8.
   PubMed Web of Science ®Google Scholar
• Stuhr LEB, Ask JA, Tyssebotn I. Increased cardiac contractility in rats exposed to 5 bar. Acta Physiol Scand 1989; 136: 167–76.
   PubMedGoogle Scholar
• Stuhr LEB, Ask JA, Tyssebotn I. Cardiovascular changes in anesthetized rats during exposure to 30 bar. Undersea Biomed Res 1990; 17: 383–93.
   Google Scholar
• Ask J, Tyssebotn I. Positive inotropic effect on the rat atrial myocardium compressed to 5, 10 and 30 bar. Acta Physiol Scand 1988; 134: 277–83.
   PubMedGoogle Scholar
• Ask J, Tyssebotn I. Positive inotropic effect on human atrial myocardium exposed to 30 bar. Undersea Biomed Res 1991; 18: 138.
   Google Scholar